Advances in diagnosis and treatment of metastatic cervical cancer

Haoran Li, Xiaohua Wu, Xi Cheng, Haoran Li, Xiaohua Wu, Xi Cheng

Abstract

Cervical cancer is one of the most common cancers in women worldwide. The outcome of patients with metastatic cervical cancer is poor. We reviewed the relevant literature concerning the treatment and diagnosis of metastatic cervical cancer. There are two types of metastasis related to different treatments and survival rates: hematogenous metastasis and lymphatic metastasis. Patients with hematogenous metastasis have a higher risk of death than those with lymphatic metastasis. In terms of diagnosis, fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) and PET-computed tomography are effective tools for the evaluation of distant metastasis. Concurrent chemoradiotherapy and subsequent chemotherapy are well-tolerated and efficient for lymphatic metastasis. As for lung metastasis, chemotherapy and/or surgery are valuable treatments for resistant, recurrent metastatic cervical cancer and chemoradiotherapy may be the optimal choice for stage IVB cervical cancer. Chemotherapy and bone irradiation are promising for bone metastasis. A better survival is achieved with multimodal therapy. Craniotomy or stereotactic radiosurgery is an optimal choice combined with radiotherapy for solitary brain metastases. Chemotherapy and palliative brain radiation may be considered for multiple brain metastases and other organ metastases.

Keywords: Diagnosis; Neoplasm Metastasis; Therapeutics; Uterine Cervical Neoplasms.

Conflict of interest statement

Conflict of Interest: No potential conflict of interest relevant to this article was reported.

References

    1. Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J. 2003;9:348–359.
    1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–1403.
    1. van Meir H, Kenter GG, Burggraaf J, Kroep JR, Welters MJ, Melief CJ, et al. The need for improvement of the treatment of advanced and metastatic cervical cancer, the rationale for combined chemo-immunotherapy. Anticancer Agents Med Chem. 2014;14:190–203.
    1. Scheidler J, Hricak H, Yu KK, Subak L, Segal MR. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA. 1997;278:1096–1101.
    1. Shen G, Zhou H, Jia Z, Deng H. Diagnostic performance of diffusion-weighted MRI for detection of pelvic metastatic lymph nodes in patients with cervical cancer: a systematic review and meta-analysis. Br J Radiol. 2015;88:20150063.
    1. Yen TC, Lai CH, Ma SY, Huang KG, Huang HJ, Hong JH, et al. Comparative benefits and limitations of 18F-FDG PET and CT-MRI in documented or suspected recurrent cervical cancer. Eur J Nucl Med Mol Imaging. 2006;33:1399–1407.
    1. Choi HJ, Ju W, Myung SK, Kim Y. Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis. Cancer Sci. 2010;101:1471–1479.
    1. Yen TC, See LC, Chang TC, Huang KG, Ng KK, Tang SG, et al. Defining the priority of using 18F-FDG PET for recurrent cervical cancer. J Nucl Med. 2004;45:1632–1639.
    1. Chao A, Ho KC, Wang CC, Cheng HH, Lin G, Yen TC, et al. Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases. Gynecol Oncol. 2008;110:172–178.
    1. Qiu JT, Ho KC, Lai CH, Yen TC, Huang YT, Chao A, et al. Supraclavicular lymph node metastases in cervical cancer. Eur J Gynaecol Oncol. 2007;28:33–38.
    1. Miccò M, Vargas HA, Burger IA, Kollmeier MA, Goldman DA, Park KJ, et al. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. Eur J Radiol. 2014;83:1169–1176.
    1. Beiderwellen K, Grueneisen J, Ruhlmann V, Buderath P, Aktas B, Heusch P, et al. [(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results. Eur J Nucl Med Mol Imaging. 2015;42:56–65.
    1. Grueneisen J, Beiderwellen K, Heusch P, Buderath P, Aktas B, Gratz M, et al. Correlation of standardized uptake value and apparent diffusion coefficient in integrated whole-body PET/MRI of primary and recurrent cervical cancer. PLoS One. 2014;9:e96751.
    1. Nogami Y, Banno K, Irie H, Iida M, Kisu I, Masugi Y, et al. The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it. Jpn J Clin Oncol. 2015;45:26–34.
    1. Nogami Y, Iida M, Banno K, Kisu I, Adachi M, Nakamura K, et al. Application of FDG-PET in cervical cancer and endometrial cancer: utility and future prospects. Anticancer Res. 2014;34:585–592.
    1. Frumovitz M, Querleu D, Gil-Moreno A, Morice P, Jhingran A, Munsell MF, et al. Lymphadenectomy in locally advanced cervical cancer study (LiLACS): Phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2-IVA cervical cancer. J Minim Invasive Gynecol. 2014;21:3–8.
    1. Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, et al. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol. 2010;28:2108–2113.
    1. Xue F, Lin LL, Dehdashti F, Miller TR, Siegel BA, Grigsby PW. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy. Gynecol Oncol. 2006;101:147–151.
    1. Kim HS, Kim T, Lee ES, Kim HJ, Chung HH, Kim JW, et al. Impact of chemoradiation on prognosis in stage IVB cervical cancer with distant lymphatic metastasis. Cancer Res Treat. 2013;45:193–201.
    1. Jeon W, Koh HK, Kim HJ, Wu HG, Kim JH, Chung HH. Salvage radiotherapy for lymph node recurrence after radical surgery in cervical cancer. J Gynecol Oncol. 2012;23:168–174.
    1. Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol. 2001;19:3745–3749.
    1. Vural GU, Akkas BE, Demirel BB. Standardized uptake value and metabolic tumor volume measured by ¹⁸F FDG PET/CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma. Rev Esp Med Nucl Imagen Mol. 2014;33:268–273.
    1. Yen TC, See LC, Lai CH, Tsai CS, Chao A, Hsueh S, et al. Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer. Eur J Nucl Med Mol Imaging. 2008;35:493–501.
    1. Gouy S, Morice P, Narducci F, Uzan C, Martinez A, Rey A, et al. Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging. J Clin Oncol. 2013;31:3026–3033.
    1. Vandeperre A, Van Limbergen E, Leunen K, Moerman P, Amant F, Vergote I. Para-aortic lymph node metastases in locally advanced cervical cancer: Comparison between surgical staging and imaging. Gynecol Oncol. 2015;138:299–303.
    1. Gouy S, Morice P, Narducci F, Uzan C, Gilmore J, Kolesnikov-Gauthier H, et al. Nodal-staging surgery for locally advanced cervical cancer in the era of PET. Lancet Oncol. 2012;13:e212–20.
    1. Recio FO, Piver MS, Hempling RE. Pretreatment transperitoneal laparoscopic staging pelvic and paraaortic lymphadenectomy in large (> or = 5 cm) stage IB2 cervical carcinoma: report of a pilot study. Gynecol Oncol. 1996;63:333–336.
    1. Gil-Moreno A, Franco-Camps S, Cabrera S, Pérez-Benavente A, Martínez-Gómez X, Garcia A, et al. Pretherapeutic extraperitoneal laparoscopic staging of bulky or locally advanced cervical cancer. Ann Surg Oncol. 2011;18:482–489.
    1. Hertel H, Köhler C, Elhawary T, Michels W, Possover M, Schneider A. Laparoscopic staging compared with imaging techniques in the staging of advanced cervical cancer. Gynecol Oncol. 2002;87:46–51.
    1. Marnitz S, Köhler C, Roth C, Füller J, Hinkelbein W, Schneider A. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol Oncol. 2005;99:536–544.
    1. Marnitz S, Schram J, Budach V, Sackerer I, Vercellino GF, Sehouli J, et al. Extended field chemoradiation for cervical cancer patients with histologically proven para-aortic lymph node metastases after laparaoscopic lymphadenectomy. Strahlenther Onkol. 2015;191:421–428.
    1. Smits RM, Zusterzeel PL, Bekkers RL. Pretreatment retroperitoneal para-aortic lymph node staging in advanced cervical cancer: a review. Int J Gynecol Cancer. 2014;24:973–983.
    1. Park JY, Lim MC, Lim SY, Bae JM, Yoo CW, Seo SS, et al. Port-site and liver metastases after laparoscopic pelvic and para-aortic lymph node dissection for surgical staging of locally advanced cervical cancer. Int J Gynecol Cancer. 2008;18:176–180.
    1. Kodaira T, Karasawa K, Shimizu T, Tanaka Y, Matsuda T, Murakami A, et al. Clinical efficacy of applying four-field portals to paraaortic irradiation in the treatment of cervical carcinoma. Radiat Oncol Investig. 1999;7:170–177.
    1. Ng BH, Rozita A, Adlinda A, Lee WC, Wan Zamaniah W. Extended field radiotherapy with or without chemotherapy in patients with cervical cancer and positive para-aortic lymph nodes: a single institution retrospective review. Asian Pac J Cancer Prev. 2015;16:3827–3833.
    1. Yoon HI, Cha J, Keum KC, Lee HY, Nam EJ, Kim SW, et al. Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis. Radiat Oncol. 2015;10:18.
    1. Kim YS, Kim JH, Ahn SD, Lee SW, Shin SS, Nam JH, et al. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys. 2009;74:1522–1528.
    1. Malfetano JH, Keys H. Aggressive multimodality treatment for cervical cancer with paraaortic lymph node metastases. Gynecol Oncol. 1991;42:44–47.
    1. Ke GH, Huang X, Huang XW, Liu SP, Wu XH. Extended-field intensity modulated radiation therapy and intra-cavitary brachytherapy combined with chemotherapy for stage Ib1-IVa cervical cancer with positive para-aortic lymph nodes. Zhonghua Fu Chan Ke Za Zhi. 2013;48:649–653.
    1. Walker JL, Morrison A, DiSilvestro P, von Gruenigen VE, Gynecologic Oncology Group A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: a Gynecologic Oncology Group study. Gynecol Oncol. 2009;112:78–84.
    1. Jang H, Chun M, Cho O, Heo JS, Ryu HS, Chang SJ. Prognostic factors and treatment outcome after radiotherapy in cervical cancer patients with isolated para-aortic lymph node metastases. J Gynecol Oncol. 2013;24:229–235.
    1. Wu SY, Huang EY, Chanchien CC, Lin H, Wang CJ, Sun LM, et al. Prognostic factors associated with radiotherapy for cervical cancer with computed tomography-detected para-aortic lymph node metastasis. J Radiat Res (Tokyo) 2014;55:129–138.
    1. Kazumoto T, Kato S, Yokota H, Hasumi Y, Kino N, Horie K, et al. Is a low dose of concomitant chemotherapy with extended-field radiotherapy acceptable as an efficient treatment for cervical cancer patients with metastases to the para-aortic lymph nodes? Int J Gynecol Cancer. 2011;21:1465–1471.
    1. Chung YL, Jian JJ, Cheng SH, Hsieh CI, Tan TD, Chang HJ, et al. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study. Gynecol Oncol. 2005;97:126–135.
    1. Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Chou HH, et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2004;60:249–257.
    1. Ho KC, Wang CC, Qiu JT, Lai CH, Hong JH, Huang YT, et al. Identification of prognostic factors in patients with cervical cancer and supraclavicular lymph node recurrence. Gynecol Oncol. 2011;123:253–256.
    1. Kim JY, Kim JY, Kim JH, Yoon MS, Kim J, Kim YS. Curative chemoradiotherapy in patients with stage IVB cervical cancer presenting with paraortic and left supraclavicular lymph node metastases. Int J Radiat Oncol Biol Phys. 2012;84:741–747.
    1. Tran BN, Grigsby PW, Dehdashti F, Herzog TJ, Siegel BA. Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix. Gynecol Oncol. 2003;90:572–576.
    1. Lee SH, Lee SH, Lee KC, Lee KB, Shin JW, Park CY, et al. Radiation therapy with chemotherapy for patients with cervical cancer and supraclavicular lymph node involvement. J Gynecol Oncol. 2012;23:159–167.
    1. Carlson V, Delclos L, Fletcher GH. Distant metastases in squamous-cell carcinoma of the uterine cervix. Radiology. 1967;88:961–966.
    1. Kim K, Cho SY, Kim BJ, Kim MH, Choi SC, Ryu SY. The type of metastasis is a prognostic factor in disseminated cervical cancer. J Gynecol Oncol. 2010;21:186–190.
    1. Vermorken JB. The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a review. Int J Gynecol Cancer. 1993;3:129–142.
    1. Zighelboim I, Taylor NP, Powell MA, Gibb RK, Rader JS, Mutch DG, et al. Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy. Radiat Med. 2006;24:625–630.
    1. Ishikawa M, Nakayama K, Rahman MT, Rahman M, Katagiri A, Katagiri H, et al. A case of stage IVb cervical carcinoma in which survival was prolonged by two different chemotherapies and CCRT. Gan To Kagaku Ryoho. 2012;39:451–455.
    1. Ki EY, Lee KH, Park JS, Hur SY. A clinicopathological review of pulmonary metastasis from uterine cervical cancer. Cancer Res Treat. 2016;48:266–272.
    1. Clavero JM, Deschamps C, Cassivi SD, Allen MS, Nichols FC, 3rd, Barrette BA, et al. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy. Ann Thorac Surg. 2006;81:2004–2007.
    1. Yamamoto K, Yoshikawa H, Shiromizu K, Saito T, Kuzuya K, Tsunematsu R, et al. Pulmonary metastasectomy for uterine cervical cancer: a multivariate analysis. Ann Thorac Surg. 2004;77:1179–1182.
    1. Shu T, Bai P, Zhang R, Li S. Clinical analysis and prognostic factors in 106 patients with stage Ia-IIb cervical cancer with pulmonary metastasis. Zhonghua Zhong Liu Za Zhi. 2014;36:703–707.
    1. González Casaurrán G, Simón Adiego C, Peñalver Pascual R, Moreno Mata N, Lozano Barriuso MA, González Aragoneses F. Surgery of female genital tract tumour lung metastases. Arch Bronconeumol. 2011;47:134–137.
    1. Yano T, Shoji F, Maehara Y. Current status of pulmonary metastasectomy from primary epithelial tumors. Surg Today. 2009;39:91–97.
    1. Seki M, Nakagawa K, Tsuchiya S, Matsubara T, Kinoshita I, Weng SY, et al. Surgical treatment of pulmonary metastases from uterine cervical cancer. Operation method by lung tumor size. J Thorac Cardiovasc Surg. 1992;104:876–881.
    1. Anderson TM, McMahon JJ, Nwogu CE, Pombo MW, Urschel JD, Driscoll DL, et al. Pulmonary resection in metastatic uterine and cervical malignancies. Gynecol Oncol. 2001;83:472–476.
    1. Lim MC, Lee HS, Seo SS, Kim MS, Kim JY, Zo JI, et al. Pathologic diagnosis and resection of suspicious thoracic metastases in patients with cervical cancer through thoracotomy or video-assisted thoracic surgery. Gynecol Oncol. 2010;116:478–482.
    1. Shiromizu K, Kasamatsu T, Takahashi M, Kikuchi A, Yoshinari T, Matsuzawa M. A clinicopathological study of postoperative pulmonary metastasis of uterine cervical carcinomas. J Obstet Gynaecol Res. 1999;25:245–249.
    1. Saijo N. Chemotherapy against pulmonary metastasis from uterine cervical carcinoma. Gan To Kagaku Ryoho. 1982;9:992–997.
    1. Onishi Y, Hatae M. A case of complete response of metastasis of cervical cancer with a combination of CBDCA and 5′-DFUR. Gan To Kagaku Ryoho. 1998;25:601–604.
    1. Fujii M, Okabe K, Toki H, Araki Y, Masaoka H. Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis. Gan To Kagaku Ryoho. 1984;11:342–343.
    1. Panek G, Gawrychowski K, Sobiczewski P, Derlatka P, Danska-Bidzinska A, Gmyrek L, et al. Results of chemotherapy for pulmonary metastases of carcinoma of the cervix in patients after primary surgical and radiotherapeutic management. Int J Gynecol Cancer. 2007;17:1056–1061.
    1. Yonezawa M, Seki A, Numoto A, Kawada K, Eguchi K, Kudo T. Successful treatment of metastatic pulmonary tumors by bronchial arterial infusion chemotherapy in two patients with locally well controlled uterine cancer. Acta Med Okayama. 1994;48:109–112.
    1. Miyamoto T. Antitumor effects and pulmonary toxicity of bleomycin administered by continuous subcutaneous infusion in patients with advanced cervical cancer. Gan To Kagaku Ryoho. 1987;14:1830–1835.
    1. Disibio G, French SW. Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med. 2008;132:931–939.
    1. Agarwal U, Dahiya P, Chauhan A, Sangwan K, Purwar P. Scalp metastasis in carcinoma of the uterine cervix--a rare entity. Gynecol Oncol. 2002;87:310–312.
    1. Thanapprapasr D, Nartthanarung A, Likittanasombut P, Na Ayudhya NI, Charakorn C, Udomsubpayakul U, et al. Bone metastasis in cervical cancer patients over a 10-year period. Int J Gynecol Cancer. 2010;20:373–378.
    1. Babar S, Rockall A, Goode A, Shepherd J, Reznek R. Magnetic resonance imaging appearances of recurrent cervical carcinoma. Int J Gynecol Cancer. 2007;17:637–645.
    1. Fulcher AS, O’Sullivan SG, Segreti EM, Kavanagh BD. Recurrent cervical carcinoma: typical and atypical manifestations. Radiographics. 1999;19(suppl_1):S103–16.
    1. Nartthanarung A, Thanapprapasr K, Udomsubpayakul U, Thanapprapasr D. Age and survival of cervical cancer patients with bone metastasis. Asian Pac J Cancer Prev. 2014;15:8401–8404.
    1. Kumar R, Gupta R, Khullar S, Padhy AK, Julka PK, Malhotra A. Bone scanning for bone metastasis in carcinoma cervix. J Assoc Physicians India. 2000;48:808–810.
    1. du Toit JP, Grove DV. Radioisotope bone scanning for the detection of occult bony metastases in invasive cervical carcinoma. Gynecol Oncol. 1987;28:215–219.
    1. Hirnle P, Mittmann KP, Schmidt B, Pfeiffer KH. Indications for radioisotope bone scanning in staging of cervical cancer. Arch Gynecol Obstet. 1990;248:21–23.
    1. Zhao Y, Wang JL, Wei LH, Bao DM. Clinical analysis of eight cases of bone metastasis of uterine carcinomas. Zhonghua Fu Chan Ke Za Zhi. 2006;41:822–825.
    1. Pasricha R, Tiwari A, Aggarwal T, Lal P. Carcinoma of uterine cervix with isolated metastasis to fibula and its unusual behavior: report of a case and review of literature. J Cancer Res Ther. 2006;2:79–81.
    1. Hamanishi J, Higuchi T, Mandai M, Fukuhara K, An M, Nakayama T, et al. Intractable recurrent cervical cancer with pelvic bone involvement successfully treated with external hemipelvectomy. J Obstet Gynaecol Res. 2008;34:112–116.
    1. Ratanatharathorn V, Powers WE, Steverson N, Han I, Ahmad K, Grimm J. Bone metastasis from cervical cancer. Cancer. 1994;73:2372–2379.
    1. Yu GZ, Yao ZH, Sun JH. Bone metastases from cancer of the cervix. Zhonghua Zhong Liu Za Zhi. 1994;16:231–233.
    1. Kanayama T, Mabuchi S, Fujita M, Kimura T. Calcaneal metastasis in uterine cervical cancer: a case report and a review of the literature. Eur J Gynaecol Oncol. 2012;33:524–525.
    1. Yoon A, Choi CH, Kim HJ, Park JY, Lee YY, Kim TJ, et al. Contributing factors for bone metastasis in uterine cervical cancer. Int J Gynecol Cancer. 2013;23:1311–1317.
    1. Wu JS, Wong RK, Lloyd NS, Johnston M, Bezjak A, Whelan T, Supportive Care Guidelines Group of Cancer Care Ontario Radiotherapy fractionation for the palliation of uncomplicated painful bone metastases - an evidence-based practice guideline. BMC Cancer. 2004;4:71.
    1. Chow E, Zeng L, Salvo N, Dennis K, Tsao M, Lutz S. Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol (R Coll Radiol) 2012;24:112–124.
    1. Dewdney A, Selvarajah U. A ‘hot’ leg: a rare case of isolated long bone metastases from cervical cancer. Anticancer Res. 2010;30:2949–2951.
    1. Koike Y, Takizawa K, Ogawa Y, Muto A, Yoshimatsu M, Yagihashi K, et al. Transcatheter arterial chemoembolization (TACE) or embolization (TAE) for symptomatic bone metastases as a palliative treatment. Cardiovasc Intervent Radiol. 2011;34:793–801.
    1. Kurokawa T, Tamakuma S. Two cases of cancer with bone metastases treated with local therapy. Gan To Kagaku Ryoho. 1993;20:1717–1719.
    1. Tsubamoto H, Inoue K, Ukita Y, Ito Y, Kanazawa R. Long-term remission after multiple bone metastases following cervical cancer: A case report. Gynecol Oncol Case Rep. 2013;5:22–24.
    1. Mackiewicz-Wysocka M, Pankowska M, Wysocki PJ. Progress in the treatment of bone metastases in cancer patients. Expert Opin Investig Drugs. 2012;21:785–795.
    1. Cormio G, Pellegrino A, Landoni F, Regallo M, Zanetta G, Colombo A, et al. Brain metastases from cervical carcinoma. Tumori. 1996;82:394–396.
    1. Chura JC, Shukla K, Argenta PA. Brain metastasis from cervical carcinoma. Int J Gynecol Cancer. 2007;17:141–146.
    1. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008;70:510–514.
    1. Piura E, Piura B. Brain metastases from cervical carcinoma: overview of pertinent literature. Eur J Gynaecol Oncol. 2012;33:567–573.
    1. Ikeda S, Yamada T, Katsumata N, Hida K, Tanemura K, Tsunematu R, et al. Cerebral metastasis in patients with uterine cervical cancer. Jpn J Clin Oncol. 1998;28:27–29.
    1. Erdis E. A rare metastatic region of cervix cancer; the brain. J Pak Med Assoc. 2014;64:89–90.
    1. Dincoglan F, Beyzadeoglu M, Sager O, Oysul K, Sirin S, Surenkok S, et al. Image-guided positioning in intracranial non-invasive stereotactic radiosurgery for the treatment of brain metastasis. Tumori. 2012;98:630–635.
    1. Niibe Y, Karasawa K, Nakamura O, Shinoura N, Okamoto K, Yamada R, et al. Survival benefit of stereotactic radiosurgery for metastatic brain tumors in patients with controlled primary lesions and no other distant metastases. Anticancer Res. 2003;23(5b):4157–4159.
    1. Chung SB, Jo KI, Seol HJ, Nam DH, Lee JI. Radiosurgery to palliate symptoms in brain metastases from uterine cervix cancer. Acta Neurochir (Wien) 2013;155:399–405.
    1. Mahmoud-Ahmed AS, Suh JH, Barnett GH, Webster KD, Kennedy AW. Tumor distribution and survival in six patients with brain metastases from cervical carcinoma. Gynecol Oncol. 2001;81:196–200.
    1. Kumar L, Tanwar RK, Singh SP. Intracranial metastases from carcinoma cervix and review of literature. Gynecol Oncol. 1992;46:391–392.
    1. Robinson JB, Morris M. Cervical carcinoma metastatic to the brain. Gynecol Oncol. 1997;66:324–326.
    1. Cormio G, Colamaria A, Loverro G, Pierangeli E, Di Vagno G, De Tommasi A, et al. Surgical resection of a cerebral metastasis from cervical cancer: case report and review of the literature. Tumori. 1999;85:65–67.
    1. Omari-Alaoui HE, Gaye PM, Kebdani T, El Ghazi E, Benjaafar N, Mansouri A, et al. Cerebellous metastases in patients with uterine cervical cancer. Two cases reports and review of the literature. Cancer Radiother. 2003;7:317–320.
    1. Tajran D, Berek JS. Surgical resection of solitary brain metastasis from cervical cancer. Int J Gynecol Cancer. 2003;13:368–370.
    1. Wuntkal R, Maheshwari A, Kerkar RA, Kane SV, Tongaonkar HB. Carcinoma of uterine cervix primarily presenting as carcinomatous meningitis: a case report. Aust N Z J Obstet Gynaecol. 2004;44:268–269.
    1. Amita M, Sudeep G, Rekha W, Yogesh K, Hemant T. Brain metastasis from cervical carcinoma--a case report. MedGenMed. 2005;7:26.
    1. Cordeiro JG, Prevedello DM, da Silva Ditzel LF, Pereira CU, Araújo JC. Cerebral metastasis of cervical uterine cancer: report of three cases. Arq Neuropsiquiatr. 2006;64(2A):300–302.
    1. Brown Iii JV, Epstein HD, Kim R, Micha JP, Rettenmaier MA, Mattison JA, et al. Rapid manifestation of CNS metastatic disease in a cervical carcinoma patient: a case report. Oncology. 2007;73:273–276.
    1. Park SH, Ro DY, Park BJ, Kim YW, Kim TE, Jung JK, et al. Brain metastasis from uterine cervical cancer. J Obstet Gynaecol Res. 2010;36:701–704.
    1. Marongiu A, Salvati M, D’Elia A, Arcella A, Giangaspero F, Esposito V. Single brain metastases from cervical carcinoma: report of two cases and critical review of the literature. Neurol Sci. 2012;33:937–940.
    1. Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, et al. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med. 2015;372:621–630.
    1. Hwang JH, Yoo HJ, Lim MC, Seo SS, Kang S, Kim JY, et al. Brain metastasis in patients with uterine cervical cancer. J Obstet Gynaecol Res. 2013;39:287–291.
    1. Oberhoff C, Kieback DG, Würstlein R, Deertz H, Sehouli J, van Soest C, et al. Topotecan chemotherapy in patients with breast cancer and brain metastases: results of a pilot study. Onkologie. 2001;24:256–260.
    1. Hou MM, Liu X, Wheler J, Naing A, Hong D, Bodurka D, et al. Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program. Anticancer Res. 2014;34:2349–2355.
    1. Kartalou M, Essigmann JM. Mechanisms of resistance to cisplatin. Mutat Res. 2001;478:23–43.
    1. Hill BT. Differing patterns of cross-resistance resulting from exposures to specific antitumour drugs or to radiation in vitro. Cytotechnology. 1993;12:265–288.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit